Citigroup’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-81,892
Closed -$1.37M 6050
2022
Q4
$1.37M Sell
81,892
-48,493
-37% -$819K ﹤0.01% 2341
2022
Q3
$2.24M Buy
130,385
+110,799
+566% +$1.74M ﹤0.01% 2062
2022
Q2
$153K Buy
19,586
+6,808
+53% +$58.5K ﹤0.01% 3994
2022
Q1
$141K Sell
12,778
-21,285
-62% -$238K ﹤0.01% 4261
2021
Q4
$598K Buy
34,063
+17,040
+100% +$331K ﹤0.01% 3666
2021
Q3
$344K Buy
17,023
+7,364
+76% +$189K ﹤0.01% 3870
2021
Q2
$319K Buy
9,659
+1,779
+23% +$67.1K ﹤0.01% 3978
2021
Q1
$308K Sell
7,880
-9,562
-55% -$449K ﹤0.01% 3769
2020
Q4
$761K Buy
17,442
+13,346
+326% +$456K ﹤0.01% 3821
2020
Q3
$117K Sell
4,096
-3,328
-45% -$105K ﹤0.01% 5001
2020
Q2
$270K Buy
7,424
+1,839
+33% +$51.8K ﹤0.01% 4788
2020
Q1
$101K Buy
+5,585
New +$122K ﹤0.01% 5335

Citigroup's ONEM Position: Q1 2023 in Review

Citigroup sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 81,892 shares — an estimated $1.37M sold.

Citigroup first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $2.24M in Q3 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Citigroup reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 81,892 1Life Healthcare shares in Q1 2023, an estimated $1.37M.
  • Citigroup first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Citigroup's 1Life Healthcare position peaked at $2.24M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.